Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 3
1970 2
1973 1
1976 1
1979 1
1980 1
1984 1
1985 1
1988 2
1989 3
1990 5
1992 3
1993 4
1994 3
1995 2
1996 5
1997 3
1998 4
1999 4
2000 6
2001 7
2002 7
2003 12
2004 6
2005 7
2006 3
2007 11
2008 16
2009 9
2010 14
2011 15
2012 15
2013 10
2014 19
2015 17
2016 27
2017 27
2018 24
2019 20
2020 32
2021 40
2022 28
2023 31
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms.
Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, Shaito A, Ghaddar T, Kobeissy F, Eid AH. Slika H, et al. Among authors: nasser sa. Biomed Pharmacother. 2022 Feb;146:112442. doi: 10.1016/j.biopha.2021.112442. Epub 2022 Jan 4. Biomed Pharmacother. 2022. PMID: 35062053 Free article. Review.
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.
Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Brockow K, et al. Among authors: nasser s. Allergy. 2013 Jun;68(6):702-12. doi: 10.1111/all.12142. Epub 2013 Apr 25. Allergy. 2013. PMID: 23617635
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Epac as a tractable therapeutic target.
Slika H, Mansour H, Nasser SA, Shaito A, Kobeissy F, Orekhov AN, Pintus G, Eid AH. Slika H, et al. Among authors: nasser sa. Eur J Pharmacol. 2023 Apr 15;945:175645. doi: 10.1016/j.ejphar.2023.175645. Epub 2023 Mar 7. Eur J Pharmacol. 2023. PMID: 36894048 Free article. Review.
430 results